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Inhalation of sulfur mustard (SM), a bifunctional alkylating agent that causes severe lung damage, is a
significant threat to both military and civilian populations. The mechanisms mediating its cytotoxic effects
are unknown and were investigated in the present studies. Male rats Crl:CD(SD) were anesthetized, and then
intratracheally intubated and exposed to 0.7–1.4 mg/kg SM by vapor inhalation. Animals were euthanized 6,
24, 48 h or 7 days post-exposure and bronchoalveolar lavage fluid (BAL) and lung tissue collected. Exposure
of rats to SM resulted in rapid pulmonary toxicity, including focal ulceration and detachment of the trachea
and bronchial epithelia from underlying mucosa, thickening of alveolar septal walls and increased numbers
of inflammatory cells in the tissue. There was also evidence of autophagy and apoptosis in the tissue. This
was correlated with increased BAL protein content, a marker of injury to the alveolar epithelial lining. SM
exposure also resulted in increased expression of markers of inflammation including cyclooxygenase-2
(COX-2), tumor necrosis factor-α (TNFα), inducible nitric oxide synthase (iNOS), and matrix metallopro-
teinase-9 (MMP-9), each of which has been implicated in pulmonary toxicity. Whereas COX-2, TNFα and
iNOS were mainly localized in alveolar regions, MMP-9 was prominent in bronchial epithelium. In contrast,
expression of the anti-oxidant hemeoxygenase, and the anti-inflammatory collectin, surfactant protein-D,
decreased in the lung after SM exposure. These data demonstrate that SM-induced oxidative stress and
injury are associated with the generation of cytotoxic inflammatory proteins which may contribute to the
pathogenic response to this vesicant.
© 2010 Published by Elsevier Inc.
Introduction
Sulfur mustard (SM, 2-bis-chloroethyl-sulfide) is a highly toxic
vesicant that has been used as a chemical warfare agent. The severity of
damage largely depends on the dose and duration of exposure. A major
target of SM is the lung and most mortality following SM poisoning is
due to pulmonary damage and associated infections (Kehe and Szinicz,
2005). Both acute (e.g., chest tightness, hacking cough, rhinorrhea) and
delayed (e.g., chronic bronchitis, airway hyperreactvitiy, lung fibrosis
and bronchopneumonia) effects have been reported after human
exposure to SM (Balali-Mood and Hefazi, 2006; Ghanei et al., 2008).
Toxicity is attributed to the lipophilic nature of SM which allows it to
rapidly penetrate target tissues and alkylate proteins, lipids and nucleic
acids resulting in DNA damage and cytotoxicity (Papirmeister et al.,
1991). Currently, there are no effective therapies for mitigating the
effects of SM on the lung. Towards this goal, animal models have been
developed to identify mechanistic pathways leading to tissue injury.
Both experimental and human exposure data suggest an involve-
ment of inflammatory cells and mediators in SM-induced lung injury.
Thus, following exposure of rodents or pigs to SM by inhalation or
intratracheal instillation, inflammatory cells are observed in the upper
and lower respiratory trackwhichpersist forweeks tomonths (Calvet et
al., 1999; Anderson et al., 2000, 2006, 2009; Kumar et al., 2001; Fairhall
et al., 2008; Allon et al., 2009). Similarly, in humans, increased numbers
of neutrophils and eosinophils are evident in the lung even a decade
after exposure (Beheshti et al., 2006; Rowell et al., 2009). The specific
role that these inflammatory cells play in SM-induced toxicity has not
been elucidated. In othermodels of lung injury, inflammatorymediators
released by macrophages have been shown to be key in the
pathogenesis of toxicity (Laskin et al., 2010a,b), and they may play a
similar role in the pulmonary response to SM. This is supported by
findings that administration of nonspecific anti-inflammatory agents
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protects against lung injury induced by vesicants (Calvet et al., 1994a,
1996; Wigenstam et al., 2009).
The goal of the present study was to characterize pulmonary injury
and inflammation in response to inhaled SM in a rodent model.
Elucidating specific inflammatory mediators and cell types that
accumulate in the lung in response to SM poisoning may be useful in
identifying new targets for the development of therapeutic
interventions.
Materials and methods
Animals and treatments. Male rats Crl:CD(SD) (230–260 g) were
purchased from Charles River Laboratory (Wilmington, MA) and
maintained in an AALAC approved animal care facility at the US Army
Medical Research Institute of Chemical Defense (Aberdeen, MD).
Animalswere housed individually on corncob bedding in polycarbonate
shoe box cages (Lab Products, Maywood, NJ), and provided commer-
cially certified rat chow and pyrogen-free water ad libitum. SM was
obtained from the Research Division, Chemical Research, Development
and Engineering Center (Aberdeen Proving Ground, MD) and diluted to
1.75, 2.5 or 3.5 mg/ml in absolute ethanol. Rats were exposed to 100 μl
of the appropriate SM solutions by intratracheal inhalation to achieve
final doses of 0.7, 1.0 or 1.4 mg/kg as previously described (Anderson et
al., 1996, 2000). Briefly, rats were anesthetized by intramuscular
administration of ketamine (80 mg/kg) and xylazine (10 mg/kg), and
intubated with a modified glass Pasteur pipette (approximately 6 cm
long) using a laryngoscope to visualize the larynx, and PE90 tubing as a
guide. Once in place, the endotracheal tube was secured with porous
tape. SM, diluted in 100 μl absolute ethanol to the desired dose or
ethanol alone (control), was placed in a heated water jacketed glass
Fig. 1. Histopathological changes in rat lung following SM exposure. Sections of trachea (Panels A and B, inset) and bronchus (Panels A and B), right cranial (Panels C and D), medial
(Panels E and F), caudal (Panels G and H), and accessory (Panels I and J) lobes, and left lobe (Panels K and L) of lung were prepared 48 h after exposure of rats to control (Ctl) or
1.4 mg/kg SM and stained with H & E. Solid arrows, bronchial and tracheal epithelium; dashed arrows, fibrin plug with cell debris; arrowheads, alveolar macrophages; n, neutrophil;
b, blood vessel. Original magnification 400×; Inset, 600×.
90 R. Malaviya et al. / Toxicology and Applied Pharmacology 248 (2010) 89–99
vapor generator, and spontaneously breathing rats were exposed for
50 min. The endotracheal tubewas then removed, and the rats returned
to their cages. This passive exposure system included an inlet one-way
respiratory check valve (Hans Rudolph, Inc., Kansas City, MO) to insure
breathing through the vapor generator only.
Bronchoalveolar lavage (BAL) and tissue collection. Animals were
deeply anesthetized and exsanguinated by clipping the vena cava. A
16-gauge needle was introduced into the trachea and secured using
3/0 suture. The thoracic cavity was then opened to expose the
trachea and lung. The left lung was lavaged three times with 3 ml
aliquots of sterile saline at room temperature (RT). The lavage fluid
was pooled, centrifuged at 300×g for 10 min and the supernatant
collected and stored at−80 °C until analyses. Immediately following
lavage, the left lobe, along with the right cranial, medial, caudal, and
accessory lobes of the lung were removed, snap frozen in liquid
nitrogen and stored in−80 °C.
For histologic evaluation, the trachea, bronchus and lung lobes were
removed and fixed in formalin. Sections (5 μm) were prepared, stained
with hematoxylin and eosin, and examined by lightmicroscopy. Images
were acquired using DP controller software (Ver. 3.3.1.292) from
Olympus Corporation (Center Valley, PA). The extent of inflammatory
changes including macrophage and neutrophil localization, alterations
in alveolar epithelial barriers and edema were assessed blindly by a
veterinary pathologist (Sherritta Ridgely, D.V.M, Ph.D).
Preparation of tissue lysates. Frozen tissue samples (20–200 mg)
were pulverized twice using an ice cold 316 stainless steel tissue
pulverizer (Cole-Parmer, Vernon Hills, IL). The tissue was then lysed
(330 mg/ml) in ice cold buffer (pH 7.4) consisting of 20 mM HEPES,
150 mM sodium chloride, 1 mM EGTA, 1.5 mM magnesium chloride,
10% glycerol and 1% Triton X-100 and protease inhibitors (1 mM PMSF,
10 mM sodium pyrophosphate, 50 mM sodium fluoride, 2 mM sodium
orthovanadate, 1 mM lactacystin and 5% protease inhibitor cocktail).
Samples were then centrifuged at 14,000×g for 10 min at 4 °C.
Supernatants containing tissue lysates were frozen at −80 °C until
analyses.
Protein measurement. Total protein content in cell-free BAL and
tissue lysates was quantified using a BCA protein assay kit (Pierce
Biotechnologies Inc., Rockford, IL) following the manufacturer's
directions with bovine serum albumin as the standard. All samples
were assayed in triplicate.
Antibodies. Rabbit monoclonal anti-cleaved caspase-3, polyclonal
anti-caspase-9, polyclonal anti-poly-ADP-ribose polymerase (PARP)-1,
and polyclonal anti-LC3B antibody, and horse radish peroxidase (HRP)-
conjugated secondary goat anti-rabbit and horse anti-mouse antibodies
were purchased from Cell Signaling Technology (Beverly, MA). Rabbit
monoclonal anti-MMP-9, and polyclonal anti-COX-2 antibodies were
from Abcam Inc. (Cambridge, MA). Mouse monoclonal anti-surfactant
protein-D (SP-D) and rabbit polyclonal anti-inducible nitric oxide
synthase (iNOS) antibodies were from Millipore Corp. (Billerica, MA).
Rabbit polyclonal anti-hemeoxygenase (HO)-1, rabbit polyclonal Cu/
Zn-superoxide dismutase (SOD) and Mn-SOD antibodies were from
Assay Designs (Ann Arbor, MI). Primary goat polyclonal anti-TNFα and
secondary goat anti-rabbit antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA).
Western blot analysis. Proteins (10–100 μg) were fractionated on
15% SDS polyacrylamide or 4–12% Novex Bis-Tris gels (Invitrogen, San
Diego, CA) and then transferred onto nitrocellulose membranes. Non-
specific binding was blocked by incubation of the blots with 5% non-fat
dry milk in Tris-buffered saline/Tween-20 (20 mM Tris Base, pH 7.6,
137 mM sodium chloride, and 0.1% Tween 20) for 1 h at room
temperature (RT). The blots were incubated overnight at 4 °C with
primary antibodies (1:500 to 1:1000) in Tris-buffered saline/Tween-20,
washed three times, and then incubated for 1 h at RT with HRP-
conjugated secondary antibody (1:2000–1:20,000), diluted in Tris-
buffered saline/Tween-20. Immunoreactive bands were visualized
using an ECL detection system (GE Healthcare Biosciences, Piscataway,
NJ). In some experiments membranes were stripped using Restore
Western Blot Stripping Buffer (Thermo Scientific, Rockford, IL) and
reprobed with different antibodies. Representative gels were analyzed
by densitometry using Quantity One software and ChemiDoc-XRS blot
imager (Bio-Rad Laboratories, Hercules, CA).
Immunohistochemistry. Paraffin sections (5–6 μm) from control and
SM treated animals were deparaffinized and endogenous peroxidase
quenched using 3% hydrogen peroxide diluted in methanol. Antigen
retrieval was performed by boiling the specimens for 10 min in 10 mM
sodium citrate buffer (pH 6.0) containing 0.05% Tween-20. To block
nonspecific binding, sections were incubated for 1 h at RT in blocking
buffer (Tris-buffered saline/Tween 20 containing goat or horse serum).
Sectionswere then incubated overnight at 4 °C in a humidified chamber
with primary antibody diluted in blocking buffer, followed by
incubation at RT for 30 min with biotinylated secondary antibody
(Vectastain Elite ABC kit, Vector Labs, Burlingame, CA). Binding was
visualized using an avidin-biotyinylated enzyme complex (Vectastain
Elite ABC kit) with 3, 3′-diaminobenzidine (DAB) as the substrate
(Vector Labs, Burlingame, CA).
Zymography. All reagents and gels were purchased from Invitrogen
(Carlsbad, CA) and used according to the manufacturer's directions.
Briefly, 10 μg of BAL or tissue lysate proteins were mixed with
zymogram sample buffer (Bio-Rad Labs, Hercules, CA) and subjected
to electrophoresis onNovex 10% Zymogramgels containing 0.1% gelatin
as substrate. The gels were then incubated with gentle shaking at RT in
1× Novex Zymogram Renaturing buffer for 30 min followed by 30 min
equilibration and incubation in 1× Novex ZymogramDeveloping buffer
at 37 °C overnight. The gels were stained with SimplyBlue SafeStain
(Invitrogen, Carlsbad) bymicrowaving for 1 min followedbywashing in
ultra purified MilliQ water at RT. Gelatinase (92 kDa) activity appeared
as clear a band on the gel.
Transmission electron microscopy (TEM). Frozen lung specimens
were fixed by immersion in 3% glutaraldehyde in 0.2 M sodium
cacodylate buffer pH 7.3 for 2 h. Specimens were washed in 0.2 M
sodium cacodylate buffer pH 7.3 for 10 min, postfixed in 1% osmium
tetroxide in 0.2 M sodium cacodylate buffer for 1 h and then washed
and dehydrated stepwise in graded ethanol. Samples were then
embedded in pure EPON A and B mixture with DMP-30. One micron
Fig. 2. Effects of SM on BAL protein levels. BAL, collected 6, 24 h and 7 days after
treatment of rats with control (Ctl) or SM (1 mg/kg), was assayed for protein content.
Each bar is the mean±SE (n=3–5); *Significantly different (pV0.05) from control.
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Fig. 3. Expression of caspases and PARP-1 in the lung following SM exposure. Upper Panels. Lung lysates were prepared 6 and 24 h after exposure of rats to control (Ctl) or SM (0.7, 1
or 1.4 mg/kg). Expression of caspase-9 (Casp-9), cleaved caspase-3 (Casp-3) and PARP-1 was analyzed by Western blotting. Lower Panels. Lung sections were prepared 48 h after
exposure of rats to control (Ctl) or SM (1.4 mg/kg). Sections were stained with antibody to caspase-9 or cleaved caspase-3 followed by biotinylated secondary antibodies. Binding
was visualized using a Vectastain kit. Arrows indicate bronchiolar and bronchial epithelial cells. Original magnification 600×; Inset, 1000×.
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plastic sections were cut and stained with methylene blue azure II
and examined by light microscopy. Representative areas were then
chosen for ultrathin sectioning. The sections were stained with
uranyl acetate and lead citrate and examined using a Hitachi H7650
instrument linked to an SIA digital camera (Scientific Instruments
and Applications, Duluth, GA) controlled by Maxim CCD software.
Statistical analysis. Data were analyzed using two-way ANOVA or
unpaired t-test (unequal variances). A p-value of V0.05 was considered
statistically significant.
Results
Effects of SM on lung histology and BAL protein
Histological changes in the trachea, the bronchi and each of the
lobes of the lung including the right cranial, medial, caudal, and
accessory lobes, as well as the left lobe were apparent as early as 6 h
after exposure of rats to SM, a response that persisted for at least 48 h
(Fig. 1 and not shown). At all post exposure times examined (6, 24 and
48 h), extensive focal attenuation of tracheal epithelial cells, charac-
terized by detachment of epithelium from the mucosa and loss of cilia
was noted (Fig. 1, panels A and B insets, and not shown). Focal
ulceration of tracheal mucosa was associated with luminal accumu-
lation of fibrin entrapping cell debris and small numbers of
neutrophils. The submucosa contained apoptotic nuclear debris that
was not associated with inflammatory cellular infiltrates. After
exposure to SM, but not control, the epithelium of the bronchus
showed evidence of focal ulceration, luminal fibrin plug entrapping of
low to moderate numbers of necrotic inflammatory cells and
bronchial epithelial cells (Fig. 1, panels A and B). Patchy mild
thickening of alveolar septa was also visible, characterized by
increased numbers of mononuclear cells, neutrophils and macro-
phages in the right and left lobes of the lung (Fig. 1, panels C–L). This
was most prominent in right caudal and accessory lobes, and the left
lobe. Mild to moderate perivascular edema was also frequently noted
with perivascular exudation of neutrophils and macrophages (Fig. 1,
panel L). These findings suggested that SM caused disruption of the
alveolar–epithelial barrier. To evaluate this, we measured protein
accumulation in BAL, a marker of alveolar–epithelial damage (Bhalla,
1999). Low levels of protein were detected in BAL from control
animals (Fig. 2). Treatment of rats with SM caused a 2–3 fold increase
in BAL protein concentration which was evident 24 h post exposure.
By 7 days, protein levels had returned to baseline control.
SM induces apoptosis and autophagy in the lung
In further studies we determined if lung injury induced by SM
involved apoptosis. Initially to assess apoptosis, we analyzed expression
of caspase-9, an initiator caspase activated following damage to
mitochondrial membranes (Kumar, 2007). Both intact full length
caspase-9 (51 kDa) and lower levels of cleaved caspase-9 (40 kDa)
were evident in control lungs (Fig. 3, upper panel). Whereas expression
of intact caspase-9 remained relatively constant following exposure of
rats to SM, expression of activated cleaved caspase-9 increased; this was
observed at 6 and 24 h post treatment at all doses of SM tested. We also
analyzed expression of activated caspase-3, a key effector enzyme of the
apoptotic pathway (Kumar, 2007). Western blot analyses of lung tissue
showed that cleaved caspase-3 proteins with molecular weights of 17
and 19 kDawere present in the lungs of control rats (Fig. 3, upper panel).
Treatment of the animals with SM resulted in a significant increase in
expression of these proteins. Whereas at 6 h, the 17 kDa fragment
increased, at 24 h both the 17 and 19 kDa proteins were upregulated. No
major differences were noted between 0.7 and 1.4 mg/kg SM.
Immunohistochemical analysis of lung sections confirmed that SM
treatment of the animals resulted in upregulation of both caspase-9 and
cleaved caspase3 in the epitheliumof thebronchi andbronchioles (Fig. 3,
lower panels). This was associated with epithelial cell shrinkage and
nuclear condensation, two characteristic features of apoptosis (Torchinsky
et al., 2010). This was most notable in epithelium that was detached from
thebasementmembrane.After SMinhalation, lowlevelsof caspase-3were
also evident in smooth muscle cells underlying the epithelium.
We next analyzed expression of the DNA repair enzyme, PARP-1,
which is proteolytically inactivated by caspase-3 (Soldani and Scovassi,
2002). As shown in Fig. 3 (upper panel), low levels of intact (116 kDa)
and cleaved (89 kDa) PARP-1 were present in lungs of control animals.
SMexposure caused an increase in cleavedPARP-1whichwasevident at
6 h, and persisted for 24 h, although at lower levels. At 6 h, a small
increase in expression of the intact protein was also noted.
Autophagy is a cellular stress-induced catabolic process that
involves degradation of cytoplasmic contents in characteristic
double-membrane vacuoles called autophagosomes (Virgin and
Levine, 2009). To determine if SM intoxication involved autophagy,
we analyzed expression of LC3B, a mammalian homolog of the yeast
autophagy gene Atg8 which associates with the autophagosome
membranes (Virgin and Levine, 2009). Both cytosolic LC3B-I, and
membrane bound LC3B-II were detectable in control lungs (Fig. 4,
upper panel). Treatment of rats with SM caused a transient increase
in expression of membrane bound LC3B-II, which was observed 6 h
post exposure; by 24 h, expression of this proteinwas similar in lungs
Fig. 4. SM induces autophagy in the lung. Upper Panel. Lung lysates were prepared 6 and
24 h after exposure of rats to control (Ctl) or SM (1.4 mg/kg). Expression of LC3BI and
LC3BII was analyzed by Western blotting. Lower Panel. TEM of lungs prepared 6 h after
treatment of rats with control (Ctl) or SM (1 mg/kg). Inset, autophagosome; blood
capillary (BC); type I cell (TI); endothelial cell (EC); type II cell (TII); solid arrows,
autophagosomes.
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of control and SM treated animals. To confirm SM-induced autop-
hagy, lung sections were examined by transmission electron
microscopy. Low numbers of autophagosomes were evident in
lungs from control rats (Fig. 4, lower panel). Treatment of the
animals with SM resulted in a significant increase in the number of
autophagosomes which were mainly detected in endothelial cells.
Effect of SM on antioxidant expression
In our next series of studies we analyzed the effects of SM on
expression of enzymes important in protecting the lung from oxidative
stress including HO-1 and SOD (Reddy, 2008). Immunostaining of lung
sections showed low levels of HO-1 in macrophages from control
animals (Fig. 5, upper panels). SM exposure resulted in an increase in
both the intensity of HO-1 expression, and the number of cells
expressing this antioxidant. Western blot analysis demonstrated that
the effects of SM on HO-1 expression were transient; thus by 24 h post
exposure,HO-1 expressionwasdecreased to levels belowcontrol (Fig. 5,
lower panels). In contrast to HO-1, SM exposure had nomajor effects on
expression of Cu/Zn-SOD or Mn-SOD.
Effect of SM on expression of inflammatory proteins in the lung
TNFα is a pro-inflammatory cytokine implicated in pulmonary
pathophysiology (Mukhopadhyay et al., 2006). Treatment of rats with
SM resulted in upregulation of TNFα expression in alveolarmacrophages
whichwasmost pronounced 48 h post exposure (Fig. 6, upper panel). At
this time, low levels of TNFα staining were also evident in alveolar
epithelial cells. In contrast, no TNFα immunoreactivity was detected in
lungs of control animals. iNOS is an inducible enzyme mediating the
generation of nitric oxide from L-arginine (Laskin et al., 2010b). Low level
staining of iNOSwasnoted in alveolarmacrophages andepithelial cells in
lungs of control animals (Fig. 6, middle panel). Following SM inhalation,
expression of iNOS increased in these cells. We also analyzed the effects
of SM on expression of COX-2, an arachidonic acidmetabolizing enzyme
important in generating prostaglandins. Western blot analysis revealed
low constitutive levels of COX-2 in lungs of control animals (Fig. 6, lower
panel). Exposure of rats to SM resulted in increased COX-2 expression
which was evident at 24 and 48 h. After 48 h, COX-2 was predominantly
localized in alveolarmacrophages. The effects of SMonCOX-2 expression
were dose related in the range of 0.7–1.4 mg/kg.
MMPsarematrix degradingzinc endopeptidasesupregulatedduring
pulmonary inflammatory responses (Corbel et al., 2002). Western blot
analysis of lung tissue from control animals revealed the presence of
MMP-9 protein, most likely due to the ethanol vehicle (Fig. 7, upper
panels). MMP-9 expression increased significantly following SM
treatment of rats. This was evident at 6 h and persisted for at least
24 h after exposure. The effects of SM onMMP-9 expressionwere dose-
dependent reaching a maximum at 1.4 mg/kg. Immunohistochemical
analysis of the lung tissue indicated thatMMP-9wasup-regulated in the
bronchiolar epitheliumand alveolarmacrophages (Fig. 7, lower panels).
MMP-9 was also detected in BAL beginning at 6 h and persisting for at
least 7 days after SM exposure (Fig. 7, upper panels). SM induced
increases in MMP-9 expression after SM exposure correlated with
increases in 92 kDa gelatinase activity in both tissue and BAL, as
measured by zymography. In the tissue, greater gelatinase activity was
observed at thehighestdoseof SMand24 hafter exposure,while inBAL,
gelatinase activity remained relatively constant between 6 h and 7 days
post SM exposure. In contrast toMMP-9,MMP-2 expression in lung and
BAL was unaffected by SM (data not shown).
SP-D is a pulmonary collectin known to play a role in negatively
regulating lung inflammation (Crouch, 2000). SP-D was constitu-
tively expressed in lungs of control rats (Fig. 8, upper panel).
Treatment of the animals with SM caused a time-dependent
decrease in SP-D in the lung which was most pronounced at 24 h.
At this time, no major differences were noted between the different
doses of SM tested. Immunohistochemistry revealed that in lungs of
control animals, SP-D was mainly expressed in bronchiolar epithe-
lium and type II alveolar epithelial cells (Fig. 8, lower panels);
alveolarmacrophages either stainedweakly orwere negative for SP-
D. Whereas exposure of rats to SM resulted in a significant decrease
in SP-D expression in bronchiolar epithelium and type II cells, a
marked increase in this protein was noted in alveolar macrophages.
SP-D was also detectable in BAL from control animals. While SM had
no major effects on BAL SP-D levels after 6 or 24 h, a significant
increase in levels of SP-D were observed 7 days post-exposure.
Fig. 5. Effects of SM on expression of antioxidants. Upper Panels. Lung sections prepared 6 h after treatment of rats with control (Ctl) or SM (1 mg/kg) were stained with antibody to
HO-1 followed by a biotinylated secondary antibody. Binding was visualized using a Vectastain kit. Arrowheads indicate alveolar macrophages. Original magnification 600×; Inset,
1000×. Lower Panels. Lung lysates prepared 6 and 24 h after exposure of rats to control (Ctl) or SM (1 mg/kg) were analyzed for HO-1, Cu/Zn-SOD and Mn-SOD byWestern blotting.
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Discussion
Accumulating evidence suggests that mediators released from
inflammatory cells contribute to lung injury induced by diverse
pulmonary toxicants (Laskin et al., 2010a). The role of inflammatory
mediators in SM-induced pulmonary injury is unknown. Findings that
anti-inflammatory steroids, such as betamethasone inhibit SM-
induced airway injury and hyperresponsivness, suggest that phago-
cytic leukocytes are involved in the pathogenic response (Calvet et al.,
1994a, 1996). This is supported by reports that inhaled corticosteroids
improve pulmonary function in patients with chronic bronchiolitis as
a result of SM inhalation (Ghanei and Harandi, 2007). In the present
studies we characterized pulmonary injury and inflammatory
responses to inhaled SM in a rodent model. Identification of the
specific cytotoxic/proinflammatory mediators involved in SM-in-
duced lung injury may help in the development of agents to mitigate
the toxicity of this vesicant.
Exposure of rats to inhaled SM resulted in rapid pulmonary
toxicity. Thus, within 6 h of exposure, histopathologic changes were
noted in the upper airways; these included detachment of tracheal
and bronchial epithelial lining from the basement membrane,
deposits of fibrin containing cellular debris in the airway lumen,
and edema of the submucosal lining. Similar alterations in the airway
epithelium have been described in the lungs of rodents exposed to SM
(Calvet et al., 1994b, 1996, 1999; Anderson et al., 1996; Guignabert et
al., 2005). Inhaled SM also caused lower airway effects including
thickening of alveolar septal walls and perivascular edema suggesting
potential alterations in the integrity of alveolar epithelial lining. This
was supported by our findings that BAL protein levels and cells
(Anderson et al., 1996) increased significantly after exposure of rats to
SM. These data are consistent with previous reports of mustard-
induced alveolar epithelial damage in rodents (Guignabert et al.,
2005; McClintock et al., 2006). Structural alterations in the lung were
accompanied by inflammatory cell infiltration into the airways and
parenchyma, as assessed histologically, and by increased numbers of
cells recovered in BAL (Calvet et al., 1999; Anderson et al., 2000). The
majority of these inflammatory cells were macrophages, supporting
the idea that phagocytic leukocytes are important in the pathogenic
response to inhaled vesicants (Gao et al., 2010).
SM is a bifunctional alkylating agent that crosslinks DNA (Papirme-
meister et al., 1991; Debiak et al., 2009). The outcome of the response to
SM depends on the extent of alkylation and crosslinking. At high doses,
alkylation may be extensive resulting in activation of initiator and
effector caspases and induction of apoptosis (Debiak et al., 2009). The
Fig. 6. Effects of SM on expression of inflammatory proteins in the lungs. Upper Panels. Lung sections, prepared 48 h after exposure of rats to control (Ctl) or SM (1.4 mg/kg), were
stainedwith antibodies to TNFα, iNOS or COX-2, followed by biotinylated secondary antibodies. Bindingwas visualized using a Vectastain kit. Arrowheads, alveolarmacrophages;
arrow, epithelial cells. Original magnification 600×; Inset, 1000×. Lower Panels. Lung lysates were prepared 6 and 24 h after exposure of rats to control (Ctl) or SM (0.7, 1 or
1.4 mg/kg). COX-2 protein expression was analyzed by Western blotting.
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present studies demonstrate that inhaled SM induces alterations in
bronchial epithelial cells that are characteristic of apoptosis including
cell shrinkage and chromatin condensation. Interestingly, this was
prominent in epithelium that was detached from the basement
membrane. These findings are consistent with previous reports that
SM induces cell detachment-dependent apoptosis or anoikis (Sourdeval
et al., 2006). The mechanisms underlying epithelial detachment in the
lung followingSMexposure areunknown. Inkeratinocytes, SMhasbeen
reported to modify intermediate filaments that are required for
maintaining connections between epithelial cells and basal lamina,
and a similar process may occur in the lung (Dillman et al., 2003; Hess
and FitzGerald, 2007; Mol et al., 2008).
A hallmark of apoptosis is sequential activation of cysteine proteases
including caspase-9, which initiates apoptosis, and its downstream
target, caspase-3, an executioner caspase (Cusimano et al., 2009).
Western blot analyses of lung tissue showed that SM inhalation resulted
in activation of both caspase-9 and caspase-3. This was observedwithin
6 h of SM exposure and persisted for at least 24 h. Immunohistochem-
ical analysis of tissue sections revealed that the caspases were localized
mainly in the bronchial epithelium. Similar increases in expression of
activated caspases have been described in alveolar macrophages
isolated from SM treated rats, and in bronchial/tracheal and small
airway epithelial cells treated in vitro with SM (Sourdeval et al., 2006;
Ray et al., 2008, 2010). These data provide additional support for a link
between SM-induced lung injury and apoptosis.
PARP-1 is a nuclear repair enzyme activated following DNA
damage (Debiak et al., 2009). Cleavage of PARP-1 by caspases into
89- and 24-kDa fragments is considered a feature of late apoptosis.
Following SM inhalation, we found evidence of increased expression
of both intact and cleaved PARP-1 in the lung. These data confirm that
SM induces DNA damage, and that this is linked to apoptosis (Kehe et
al., 2009). The role of PARP-1 in the toxicity of vesicants has received
considerable attention (Debiak et al., 2009). This enzyme mediates
the repair of single stranded DNA damage and is thought to be key in
maintaining survival and genomic integrity under genotoxic stress.
Finding that PARP-1 is rapidly inactivated in the lung following SM
exposure suggests a potential mechanism contributing to tissue injury
induced by this vesicant.
Autophagy is a tightly regulated catabolic process involving
intracellular self-degradation that has been shown to play a role in
normal cell growth, development and homeostasis. However, under
conditions of oxidative stress, autophagy is thought to represent an
alternative form of non-apoptotic cell death (Uchiyama et al., 2008).
Transmission electron microscopy revealed the presence of autophago-
somes in the lungs of rats treated with SM. These were evident as early
as 6 h after treatment and persisted for at least 48 h. Thiswas correlated
with increased expression of LC3B-II, a lipidated form of LC3B-I protein,
which is known to associate with autophagosome membranes (Virgin
and Levine, 2009). Long term consequences of exposure to SM include
the development of chronic obstructive pulmonary disease (COPD).
Markers of autophagy have been noted in the lungs of patients in the
early stages of the development of this disease (Chen et al., 2008). The
fact that there is evidence of autophagy in lungs of animals shortly after
exposure to SM suggests that this cytotoxic mechanism may be
important in the pathogenesis of chronic lung diseases in exposed
subjects. This is supported byfindings that exposure to cigarette smoke,
which is also a causative agent for COPD, induces autophagy in lung
epithelial cells (Chen et al., 2008).
A characteristic response of cells and tissues to oxidative stress is
upregulation of HO-1, a phase II enzyme with antioxidant and
Fig. 7. Effects of SM on MMP-9 and gelatinase. Upper Panels. Lung lysates and BAL fluids were collected 6, 24 h and 7 days after exposure of rats to control (Ctl) or SM (0.7, 1 or
1.4 mg/kg).MMP-9 protein expressionwas analyzed byWestern blotting (WB). Gelatinase activity was analyzed by zymography. Lower Panels. Lung sections, prepared 48 h after
exposure of rats to control (Ctl) or SM (1.4 mg/kg), were stained with antibody to MMP-9 followed by a biotinylated secondary antibody. Binding was visualized using a
Vectastain kit. Arrows, bronchiolar epithelium; arrowheads, alveolar macrophages. Original magnification 600×; Inset, 1000×.
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antiapoptotic activity. Following SM inhalation, a rapid and
transient induction of HO-1 protein was observed in the lung,
confirming that SM induced toxicity is associated with oxidative
stress (Korkmaz et al., 2006). The finding that HO-1 expression was
predominantly localized in alveolar macrophages, suggests that
these cells are a major source of cytotoxic oxidants. Interestingly,
upregulation of HO-1 was transient and by 24 h was below control
levels. A similar biphasic effect on HO-1 has been described after
exposure of macrophages to cigarette smoke (Goven et al., 2009).
Themechanism underlying this effect is unknown andmay be due to
impaired transcriptional activation of the HO-1 gene (Goven et al.,
2009). In contrast to its effects on HO-1, SM inhalation had nomajor
effect on expression of Mn-SOD or Cu/Zn-SOD. These results were
surprising since intratracheal instillation of liposomes containing
SOD and catalase has been reported to ameliorate vesicant-induced
lung injury (McClintock et al., 2006; Mukherjee et al., 2009).
Moreover, a catalytic antioxidant possessing SOD and catalase
activity was effective in reducing inflammation and oxidative stress
following inhalation of 2-chloroethyl ethyl sulfide (CEES), a half
mustard analog of SM (O'Neill et al., 2010). It may be that SM
induces changes in pulmonary expression of EC-SOD, an extracel-
lular form of SOD, which is considered to be prominent in
antioxidant defense of the lung, and this remains to be determined
(Oberley-Deegan et al., 2009).
Nitric oxide is produced bymacrophages via an inducible formof the
enzyme, nitric oxide synthase. Once generated, nitric oxide readily
reacts with superoxide anion forming peroxynitrite, a long-lived
cytotoxic oxidant. Evidence suggests that these reactivenitrogen species
contribute to oxidative stress and tissue damage induced by diverse
pulmonary toxicants (Laskin et al., 2010b). The present studies
demonstrate that iNOS is markedly upregulated in macrophages and
lung epithelial cells after SM exposure. These findings are consistent
with previous reports that SM upregulates iNOS expression and nitric
oxideproduction in cultured airwayepithelial cells, and amonocytic cell
line (Gao et al., 2008, 2010). The observation that SM-induced
cytotoxicity is ameliorated by blocking or reducing production of
reactive nitrogen species provides support for their role in the
pathogenesis of vesicant-induced tissue injury (Gao et al., 2008). We
also found that COX-2, which mediates the production of pro-
inflammatory eicosanoids, was upregulated in the lung after SM
treatment of rats. In contrast to iNOS, this was mainly localized in
alveolar macrophages. An involvement of COX-2 in SM-induced skin
toxicity is well documented. Thus, COX-2 is rapidly upregulated in the
skin following dermal exposure to SM; additionally, indomethacin, a
nonspecific COX inhibitor ameliorates SM-induced dermal inflamma-
tion (Yourick et al., 1995; Babin et al., 2000; Casillas et al., 2000;Nyska et
al., 2001). More recent studies have also demonstrated that COX-2
knockout mice or mice pretreated with the selective COX-2 inhibitor,
celecoxib are protected from SM-induced skin injury (Wormser et al.,
2004). It remains to be determined whether comparable protective
effects against SM poisoning are observed in the lung.
SM-induced oxidative stress is thought to be a primary event
triggering inflammation. Early response proinflammatory cytokines
such as TNFα are rapidly generated in tissues in response to oxidative
stress. It has been suggested that initiation of the free-radical-
mediated TNFα cascade is a major pathway in vesicant-induced lung
injury (Chatterjee et al., 2003; Mukhopadhyay et al., 2006). We found
that SM exposure resulted in increased expression of TNFα in the
lung, which was evident in macrophages and alveolar epithelial cells,
48 h post exposure. In contrast, Chatterjee et al. (2003) reported that
Fig. 8. Effects of SM on SP-D expression. Upper Panel. Lung tissue and BAL were collected 6, 24 h and 7 days after exposure of rats to control (Ctl) or SM (0.7, 1 or 1.4 mg/kg). SP-D
protein expression was analyzed byWestern blotting. Lower Panels. Lung sections prepared 24 h after exposure of rats to control (Ctl) or SM (1 mg/kg)were stained with antibody to
SP-D followed by biotinylated secondary antibody. Binding was visualized using a Vectastain kit. Solid arrows, bronchiolar epithelium; dashed arrows, type II cells; arrowheads,
alveolar macrophages. Original magnification 600×; Inset, 1000×.
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increases in TNFα in the lung were transient, appearing within 1 h of
exposure of animals to the half mustard, CEES, and returning to
control levels by 24 h. Differences between these results and oursmay
be due to unique responses of different species (e.g., rats versus
guinea pigs) to vesicants, the method of vesicant exposure, and/or
distinct cytotoxic properties of SM and CEES. The precise role of TNFα
in SM-induced lung injury is unknown. TNFα binds to receptors on
target cells such as macrophages resulting in activation of biochemical
signaling molecules like NFκB and AP-1, transcription factors
regulating expression of inflammatory genes including iNOS and
COX-2, and this may be important in its pathogenic actions. Recent
findings that TNFR1 knockout mice are protected from lung injury
induced by CEES, suggest a potential target for therapy to mitigate
vesicant-induced inflammatory mediator production, and potentially,
pulmonary toxicity (Sunil et al., 2009).
TNFα is also known to upregulate expression of MMPs which
degrade extracellular matrix components and have been implicated in
lung toxicity (Ohbayashi, 2002). Evidence suggests an important role of
MMPs in the toxicity of SM, not only in the lung, but also in the skin and
eye (Shakarjian et al., 2010). The present studies demonstrate that SM
caused a dose- and time-dependent increase in expression ofMMP-9 in
the lung which was mainly localized in bronchiolar epithelium and
alveolarmacrophages;MMP-9 protein and gelatinase activity were also
upregulated in BAL following SM administration to rats. These findings
are in accord with previous observations after exposure of rodents to
SM (Calvet et al., 1999; Guignabert et al., 2005; Anderson et al., 2009). It
is possible that MMP-9 plays a role in SM-induced detachment of
epithelia and epithelial cell sloughing. This is supported by findings that
MMP-9/92 kDa gelatinase B is present at epithelial detachment sites,
that this is directly correlated with SM-induced alveolar epithelial
injury, and that MMP inhibitors such as doxyclyline and illomastat
ameliorate vesicant-induced respiratory lesions (Calvet et al., 1999;
Guignabert et al., 2005; Anderson et al., 2009).
A question arises as to what controls inflammatory cell activity in
the lung following SM-induced injury. Collectins, including SP-D, are
soluble pattern recognition receptors belonging to the superfamily of
collagen containing C-type lectins. Thesemolecules are thought to be
major regulators of innate immune responses in the lung (Chroneos
et al., 2010). Whereas in its native form, SP-D possesses anti-
inflammatory activity, post-translational modification by reactive
nitrogen species results in a change in SP-D to a pro-inflammatory
protein (Guo et al., 2008). In the lung, SP-D is produced by type II
epithelial cells, Clara cells, and submucosal glands in the pulmonary
airways. Mice lacking SP-D show evidence of persistent pulmonary
inflammation, including increases in macrophage numbers and size
within the airways, increases in MMP activity, and enhanced
oxidative-nitrosative stress (Atochina-Vasserman et al., 2007). We
found that SM exposure resulted in a time-dependent decrease in
native SP-D expression in bronchiolar epithelial cells which was
directly correlatedwith inflammation and tissue injury. These results
are consistent with reports that mustards damage type II cells and
alter the surface tension of BAL, and suggest a potential mechanism
leading to the development of acute respiratory distress syndrome in
SM-exposed individuals (van Helden et al., 2004; Sinha Roy et al.,
2005; Mukhopadhyay et al., 2008). Interestingly, SP-D staining
increased in alveolar macrophages following SM exposure which
was likely due to uptake of the protein by these phagocytic cells.
Macrophages are a major source of reactive nitrogen species (Laskin
et al., 2010b). S-nitrosylation of SP-D by macrophage-derived
reactive nitrogen species may contribute to the proinflammatory
environment in the lung following SM exposure. Administration of
Curosurf surfactant, which contains SP-D, has been reported to
reduce SM-inducedmortality in guinea pigs (vanHelden et al., 2004).
These data suggest that SM-induced damage to lung surfactants such
as SP-D may render the tissue more susceptible to oxidative stress,
inflammation and injury.
In summary, the present studies demonstrate that inhalation
exposure of rats to environmentally relevant doses of SM (Willems,
1989; Eisenmenger et al., 1991) induces oxidative stress, inflamma-
tion, and tissue injury, characterized by both apoptosis and autop-
hagy. Although DNA and protein alkylation by SM are well established
consequences of exposure, precisely how these alterations lead to
pulmonary injury is unknown. Our findings that SM-induced acute
lung injury is associated with increased proinflammatory activity of
macrophages, autophagy in endothelial cells and anoikis in bronchi-
olar epithelium indicate that different lung cell populations respond
distinctly to mustard gas inhalation. These data are novel and suggest
that multifaceted approaches targeting different lung cell populations
may be an effective therapeutic strategy for mitigating the toxicity of
vesicants.
Conflict of interest
The authors declare that there are no conflicts of interest.
Acknowledgments
This work was supported by NIH Grants HL096426, AR055073,
GM034310, ES004738, CA132624, and ES005022, and by the Defense
Threat Reduction Agency-Joint Science and Technology Office,
Medical S & T Division.
References
Allon, N., Amir, A., Manisterski, E., Rabinovitz, I., Dachir, S., Kadar, T., 2009. Inhalation
exposure to sulfur mustard in the guinea pig model: clinical, biochemical and
histopathological characterization of respiratory injuries. Toxicol. Appl. Pharmacol.
241, 154–162.
Anderson, D.R., Yourick, J.J., Moeller, R.B., Petrali, J.P., Young, G.D., Byers, S.L., 1996.
Pathological changes in rat lungs following acute sulfur mustard inhalation. Inhal.
Toxicol. 8, 285–297.
Anderson, D.R., Byers, S.L., Vesely, K.R., 2000. Treatment of sulfur mustard (HD)-induced
lung injury. J. Appl. Toxicol. 20, S129–S132.
Anderson, D.R., Holmes, W.W., Lee, R.B., Dalal, S.J., Hurst, C.G., Maliner, B.I., Newmark, J.,
Smith, W.J., 2006. Sulfur mustard-induced neutropenia: treatment with granulo-
cyte colony-stimulating factor. Mil. Med. 171, 448–453.
Anderson, D.R., Taylor, S.L., Fetterer, D.P., Holmes, W.W., 2009. Evaluation of protease
inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung
injury. Toxicology 263, 41–46.
Atochina-Vasserman, E.N., Beers, M.F., Kadire, H., Tomer, Y., Inch, A., Scott, P., Guo, C.J.,
Gow, A.J., 2007. Selective inhibition of inducible NO synthase activity in vivo
reverses inflammatory abnormalities in surfactant protein D-deficient mice. J.
Immunol. 179, 8090–8097.
Babin, M.C., Ricketts, K., Skvorak, J.P., Gazaway, M., Mitcheltree, L.W., Casillas, R.P., 2000.
Systemic administration of candidate antivesicants to protect against topically
applied sulfur mustard in the mouse ear vesicant model (MEVM). J. Appl. Toxicol.
20, S141–S144.
Balali-Mood, M., Hefazi, M., 2006. Comparison of early and late toxic effects of sulfur
mustard in Iranian veterans. Basic Clin. Pharmacol. Toxicol. 99, 273–282.
Beheshti, J., Mark, E.J., Akbaei, H.M., Aslani, J., Ghanei, M., 2006. Mustard lung secrets:
long term clinicopathological study following mustard gas exposure. Pathol. Res.
Pract. 202, 739–744.
Bhalla, D.K., 1999. Ozone-induced lung inflammation and mucosal barrier disruption:
toxicology, mechanisms, and implications. J. Toxicol. Environ. Health B Crit. Rev. 2,
31–86.
Calvet, J.H., D'Ortho, M.P., Jarreau, P.H., Levame, M., Harf, A., Macquin-Mavier, I., 1994a.
Glucocorticoids inhibit sulfur mustard-induced airway muscle hyperresponsive-
ness to substance P. J. Appl. Physiol. 77, 2325–2332.
Calvet, J.H., Jarreau, P.H., Levame, M., D'Ortho, M.P., Lorino, H., Harf, A., Macquin-Mavier,
I., 1994b. Acute and chronic respiratory effects of sulfur mustard intoxication in
guinea pig. J. Appl. Physiol. 76, 681–688.
Calvet, J.H., Coste, A., Levame, M., Harf, A., Macquin-Mavier, I., Escudier, E., 1996. Airway
epithelial damage induced by sulfur mustard in guinea pigs, effects of glucocorti-
coids. Hum. Exp. Toxicol. 15, 964–971.
Calvet, J.H., Planus, E., Rouet, P., Pezet, S., Levame, M., Lafuma, C., Harf, A., D'Ortho, M.P.,
1999. Matrix metalloproteinase gelatinases in sulfur mustard-induced acute
airway injury in guinea pigs. Am. J. Physiol. 276, L754–L762.
Casillas, R.P., Kiser, R.C., Truxall, J.A., Singer, A.W., Shumaker, S.M., Niemuth, N.A.,
Ricketts, K.M., Mitcheltree, L.W., Castrejon, L.R., Blank, J.A., 2000. Therapeutic
approaches to dermatotoxicity by sulfur mustard: I. Modulation of sulfur mustard-
induced cutaneous injury in the mouse ear vesicant model. J. Appl. Toxicol. 20,
S145–S151.
98 R. Malaviya et al. / Toxicology and Applied Pharmacology 248 (2010) 89–99
Chatterjee, D., Mukherjee, S., Smith, M.G., Das, S.K., 2003. Signal transduction events in
lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J. Biochem.
Mol. Toxicol. 17, 114–121.
Chen, Z.H., Kim, H.P., Sciurba, F.C., Lee, S.J., Feghali-Bostwick, C., Stolz, D.B., Dhir, R.,
Landreneau, R.J., Schuchert, M.J., Yousem, S.A., Nakahira, K., Pilewski, J.M., Lee, J.S.,
Zhang, Y., Ryter, S.W., Choi, A.M., 2008. Egr-1 regulates autophagy in cigarette
smoke-induced chronic obstructive pulmonary disease. PLoS ONE 3, e3316.
Chroneos, Z.C., Sever-Chroneos, Z., Shepherd, V.L., 2010. Pulmonary surfactant: an
immunological perspective. Cell. Physiol. Biochem. 25, 13–26.
Corbel, M., Belleguic, C., Boichot, E., Lagente, V., 2002. Involvement of gelatinases
(MMP-2 and MMP-9) in the development of airway inflammation and pulmonary
fibrosis. Cell Biol. Toxicol. 18, 51–61.
Crouch, E.C., 2000. Surfactant protein-D and pulmonary host defense. Respir. Res. 1,
93–108.
Cusimano, E.M., Knight, A.R., Slusser, J.G., Clancy, R.L., Pierce, J.D., 2009. Mitochondria:
the hemi of the cell. Adv. Emerg. Nurs. J. 31, 54–62.
Debiak, M., Kehe, K., Burkle, A., 2009. Role of poly(ADP-ribose) polymerase in sulfur
mustard toxicity. Toxicology 263, 20–25.
Dillman, J.F., McGary, K.L., Schlager, J.J., 2003. Sulfur mustard induces the formation of
keratin aggregates in human epidermal keratinocytes. Toxicol. Appl. Pharmacol.
193, 228–236.
Eisenmenger, W., Drasch, G., von Clarmann, M., Kretschmer, E., Roider, G., 1991. Clinical
andmorphological findings onmustard gas [bis(2-chloroethyl)sulfide] poisoning. J.
Forensic Sci. 36, 1688–1696.
Fairhall, S.J., Brown, R.F., Jugg, B.J., Smith, A.J., Mann, T.M., Jenner, J., Sciuto, A.M., 2008.
Preliminary studies of sulphur mustard-induced lung injury in the terminally
anesthetized pig: exposure system and methodology. Toxicol. Mech. Methods 18,
355–362.
Gao, X., Ray, R., Xiao, Y., Ray, P., 2008. Suppression of inducible nitric oxide synthase
expression and nitric oxide production by macrolide antibiotics in sulfur
mustard-exposed airway epithelial cells. Basic Clin. Pharmacol. Toxicol. 103,
255–261.
Gao, X., Ray, R., Xiao, Y., Ishida, K., Ray, P., 2010. Macrolide antibiotics improve
chemotactic and phagocytic capacity as well as reduce inflammation in sulfur
mustard-exposed monocytes. Pulm. Pharmacol. Ther. 23, 97–106.
Ghanei, M., Harandi, A.A., 2007. Long term consequences from exposure to sulfur
mustard: a review. Inhal. Toxicol. 19, 451–456.
Ghanei, M., Adibi, I., Farhat, F., Aslani, J., 2008. Late respiratory effects of sulfur mustard:
how is the early symptoms severity involved? Chron. Respir. Dis. 5, 95–100.
Goven, D., Boutten, A., Lecon-Malas, V., Boczkowski, J., Bonay, M., 2009. Prolonged
cigarette smoke exposure decreases heme oxygenase-1 and alters Nrf2 and Bach1
expression in human macrophages: roles of the MAP kinases ERK(1/2) and JNK.
FEBS Lett. 583, 3508–3518.
Guignabert, C., Taysse, L., Calvet, J.H., Planus, E., Delamanche, S., Galiacy, S., d'Ortho, M.P.,
2005. Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea
pigs. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L67–L74.
Guo, C.J., Atochina-Vasserman, E.N., Abramova, E., Foley, J.P., Zaman, A., Crouch, E.,
Beers, M.F., Savani, R.C., Gow, A.J., 2008. S-nitrosylation of surfactant protein-D
controls inflammatory function. PLoS Biol. 6, e266.
Hess, J.F., FitzGerald, P.G., 2007. Treatment of keratin intermediate filaments with sulfur
mustard analogs. Biochem. Biophys. Res. Commun. 359, 616–621.
Kehe, K., Szinicz, L., 2005. Medical aspects of sulphur mustard poisoning. Toxicology
214, 198–209.
Kehe, K., Balszuweit, F., Steinritz, D., Thiermann, H., 2009. Molecular toxicology of sulfur
mustard-induced cutaneous inflammation and blistering. Toxicology 263, 12–19.
Korkmaz, A., Yaren, H., Topal, T., Oter, S., 2006. Molecular targets against mustard
toxicity: implication of cell surface receptors, peroxynitrite production, and PARP
activation. Arch. Toxicol. 80, 662–670.
Kumar, S., 2007. Caspase function in programmed cell death. Cell Death Differ. 14,
32–43.
Kumar, O., Sugendran, K., Vijayaraghavan, R., 2001. Protective effect of various
antioxidants on the toxicity of sulphur mustard administered to mice by inhalation
or percutaneous routes. Chem. Biol. Interact. 134, 1–12.
Laskin, D.L., Gardner, C.R., Laskin, J.D., 2010a. Phagocytes, In: Lawrence, D. (Ed.),
Comprehensive Toxicology, 2nd edition. : Immune System Toxicology, vol. 5.
Elsevier, UK, pp. 133–153.
Laskin, J.D., Heck, D.E., Laskin, D.L., 2010b. Nitric oxide pathways in toxic responses. In:
Ballantyne, B., Marrs, T., Syversen, T. (Eds.), General and Applied Toxicology. Wiley-
Blackwell, UK. Chapter 17.
McClintock, S.D., Hoesel, L.M., Das, S.K., Till, G.O., Neff, T., Kunkel, R.G., Smith, M.G.,
Ward, P.A., 2006. Attenuation of half sulfur mustard gas-induced acute lung injury
in rats. J. Appl. Toxicol. 26, 126–131.
Mol, M.A., van den Berg, R.M., Benschop, H.P., 2008. Proteomic assessment of sulfur
mustard-induced protein adducts and other protein modifications in human
epidermal keratinocytes. Toxicol. Appl. Pharmacol. 230, 97–108.
Mukherjee, S., Stone, W.L., Yang, H., Smith, M.G., Das, S.K., 2009. Protection of half sulfur
mustard gas-induced lung injury in guinea pigs by antioxidant liposomes. J.
Biochem. Mol. Toxicol. 23, 143–153.
Mukhopadhyay, S., Hoidal, J.R., Mukherjee, T.K., 2006. Role of TNFalpha in pulmonary
pathophysiology. Respir. Res. 7, 125.
Mukhopadhyay, S., Mukherjee, S., Smith, M., Das, S.K., 2008. Activation of MAPK/AP-1
signaling pathway in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard
gas analog. Toxicol. Lett. 181, 112–117.
Nyska, A., Lomnitski, L., Maronpot, R., Moomaw, C., Brodsky, B., Sintov, A., Wormser, U.,
2001. Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2
expression in sulfur mustard-induced skin. Arch. Toxicol. 74, 768–774.
Oberley-Deegan, R.E., Regan, E.A., Kinnula, V.L., Crapo, J.D., 2009. Extracellular
superoxide dismutase and risk of COPD. COPD 6, 307–312.
Ohbayashi, H., 2002. Matrix metalloproteinases in lung diseases. Curr. Protein Pept. Sci.
3, 409–421.
O'Neill, H.C., White, C.W., Veress, L.A., Hendry-Hofer, T.B., Loader, J.E., Min, E., Huang,
J., Rancourt, R.C., Day, B.J., 2010. Treatment with the catalytic metalloporphyrin
AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the
sulfur mustard analog 2-chloroethyl ethyl sulfide. Free Radic. Biol. Med. 48,
1188–1196.
Papirmeister, B., Feister, A.J., Robinson, S.I., Ford, R.D., 1991. Medical Defense Against
Mustard Gas: Toxic Mechanisms and Pharmacological Implications. CRC Press, Boca
Raton.
Ray, R., Keyser, B., Benton, B., Daher, A., Simbulan-Rosenthal, C.M., Rosenthal, D.S., 2008.
Sulfur mustard induces apoptosis in cultured normal human airway epithelial cells:
evidence of a dominant caspase-8-mediated pathway and differential cellular
responses. Drug Chem. Toxicol. 31, 137–148.
Ray, R., Simbulan-Rosenthal, C.M., Keyser, B.M., Benton, B., Anderson, D., Holmes, W.,
Trabosh, V.A., Daher, A., Rosenthal, D.S., 2010. Sulfurmustard induces apoptosis in
lung epithelial cells via a caspase amplification loop. Toxicology 271, 94–99.
Reddy, S.P., 2008. The antioxidant response element and oxidative stress modifiers in
airway diseases. Curr. Mol. Med. 8, 376–383.
Rowell, M., Kehe, K., Balszuweit, F., Thiermann, H., 2009. The chronic effects of sulfur
mustard exposure. Toxicology 263, 9–11.
Shakarjian, M.P., Heck, D.E., Gray, J.P., Sinko, P.J., Gordon, M.K., Casillas, R.P., Heindel, N.D.,
Gerecke, D.R., Laskin, D.L., Laskin, J.D., 2010. Mechanisms mediating the vesicant
actions of sulfur mustard after cutaneous exposure. Toxicol. Sci. 114, 5–19.
SinhaRoy, S.,Mukherjee, S., Kabir, S., Rajaratnam,V., Smith,M., Das, S.K., 2005. Inhibition of
cholinephosphotransferase activity in lung injury induced by 2-chloroethyl ethyl
sulfide, a mustard analog. J. Biochem. Mol. Toxicol. 19, 289–297.
Soldani, C., Scovassi, A.I., 2002. Poly(ADP-ribose) polymerase-1 cleavage during
apoptosis: an update. Apoptosis 7, 321–328.
Sourdeval, M., Lemaire, C., Deniaud, A., Taysse, L., Daulon, S., Breton, P., Brenner, C.,
Boisvieux-Ulrich, E., Marano, F., 2006. Inhibition of caspase-dependent mitochon-
drial permeability transition protects airway epithelial cells against mustard-
induced apoptosis. Apoptosis 11, 1545–1559.
Sunil, V.R., Patel, K.J., Malaviya, R., Laskin, J.D., Laskin, D.L., 2009. Inflammatory mediator
expression in the lung following exposure to the sulfurmustard analog, 2-chloroethyl
sulfide; Role of TNFR1. Am. J. Res. Crit. Care Med 179, A5863.
Torchinsky, M.B., Garaude, J., Blander, J.M., 2010. Infection and apoptosis as a combined
inflammatory trigger. Curr. Opin. Immunol. 22, 55–62.
Uchiyama, Y., Shibata, M., Koike, M., Yoshimura, K., Sasaki, M., 2008. Autophagy—
physiology and pathophysiology. Histochem. Cell Biol. 129, 407–420.
van Helden, H.P., Kuijpers, W.C., Diemel, R.V., 2004. Asthma like symptoms following
intratracheal exposureofGuineapigs to sulfurmustardaerosol: therapeutic efficacyof
exogenous lung surfactant curosurf and salbutamol. Inhal. Toxicol. 16, 537–548.
Virgin, H.W., Levine, B., 2009. Autophagy genes in immunity. Nat. Immunol. 10,
461–470.
Wigenstam, E., Rocksen, D., Ekstrand-Hammarstrom, B., Bucht, A., 2009. Treatment
with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects
after chemical-induced lung injury. Inhal. Toxicol. 21, 958–964.
Willems, J.L., 1989. Clinical management of mustard gas casualties. Ann. Med. Milit.
(Belgium) 3, 1–61.
Wormser, U., Langenbach, R., Peddada, S., Sintov, A., Brodsky, B., Nyska, A., 2004.
Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and
celecoxib-treated mice. Toxicol. Appl. Pharmacol. 200, 40–47.
Yourick, J.J., Dawson, J.S., Mitcheltree, L.W., 1995. Reduction of erythema in hairless
guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with
niacinamide, promethazine and indomethacin. J. Appl. Toxicol. 15, 133–138.
99R. Malaviya et al. / Toxicology and Applied Pharmacology 248 (2010) 89–99
